Good day, and welcome to the Montrose Environmental Group Inc. third quarter 2024 earnings call. All participants will be in the listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press star then two. Please note that this event is being recorded. I would now like to turn the conference over to Adrian Griffin, Senior Vice President in Investor Relations and Treasury. Please go ahead. Thank you, and welcome to our third quarter 2024 earnings call. Joining me on the call are Vijay Manthripragada, our President and Chief Executive Officer, and Allan Dicks, our Chief Financial Officer. During our prepared remarks today, we will refer to our earnings presentation, which is available on the investor section of our website. Our earnings release is also available on the website. Moving to slide two, I would like to remind everyone that today's call will include forward-looking statements that are subject to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ in a material way due to known and unknown risks and uncertainties that should be considered in evaluating our operating performance and financial outlook. We refer you to our recent SEC filings, including our annual report on Form 10-K for the fiscal year ended December 31st, 2023, which identify the principal risks and uncertainties that could affect any forward-looking statements, as well as our future performance. We assume no obligation to update any forward-looking statements. On today's call, we will discuss or provide certain non-GAAP financial measures, such as consolidated adjusted EBITDA, adjusted net income, and adjusted net income per share. We provide these non-GAAP results for informational purposes, and they should not be considered in isolation from the most directly comparable GAAP measures. Please see the appendix to the earnings presentation or our earnings release for a discussion of why we believe these non-GAAP measures are useful to investors, certain limitations of using these measures, and a reconciliation to their most directly comparable GAAP measure. With that, I would now like to turn the call over to Vijay, beginning on slide four. Thank you, Adrian, and welcome to all of you who are joining us today. I will start with an update on our business and our outlook, and I will then speak generally to the third quarter earnings presentation shared on our website. Allan will provide the financial highlights, and following our prepared remarks, we will host a question-and-answer session. While today's call will highlight third quarter performance, it is important to reiterate that our business is best assessed on an annual basis. Demand for environmental solutions does not consistently follow quarterly patterns, and we manage our operations using annual perspective. Before we dive into the quarter's performance, I would like to welcome our new colleagues from Origins Laboratory, an environmental lab serving Colorado and the U.S. Mountain States, who joined us in September. I would also like to take a moment to express my gratitude for the approximately 3,500 Montrose colleagues around the world. Through their continued dedication and service to our customers, in many instances, despite the personal and community challenges caused by two major hurricanes, we were able to produce another quarter of record results and further our position as a leader in the environmental industry. As for Q3 2024, we are very pleased to report another period of record results. Our quarterly revenue reached $178.7 million, and our consolidated adjusted EBITDA reached $28.3 million. Our consolidated EBITDA margin was 15.8%, which was a 190 basis point improvement over the prior year quarter. This exceptional performance was driven by robust organic growth across most of our business lines, as well as positive impacts from recent acquisitions. During the third quarter, we were particularly encouraged by the progress of Matrix Inc., which is set to achieve our targeted mid-teen EBITDA margin, an impressive improvement from their 4.6% EBITDA margin prior to joining Montrose in June of 2023. As is evident from our strong performance in Q3, we continue to benefit from healthy end-market demand as clients prepare for and respond to environmental regulations on a host of topics ranging from PFAS to methane leak detection and new air emissions standards. These tailwinds are further bolstered by growing public and private sector focus on environmental stewardship. Growing demand and industry tailwinds have supported the continued execution of our strategy and our cross-selling initiatives, which continue to drive our organic growth opportunities. With this backdrop, we remain committed to our long-term strategy, which has been in place since our inception and has facilitated significant shareholder and stakeholder value creation. However, in the near term, our priority over the coming quarters will be the redemption of our Series A2 preferred stock and subsequent deleveraging. We expect to fund this redemption via cash flow generation and incremental borrowing under our current credit facility. We do not intend to issue equity as a source of funds for the preferred redemption. Given this near-term prioritization, our team will focus on organic growth opportunities and will temporarily de-emphasize acquisitions, though the pipeline and medium to long-term acquisition opportunities remain very robust. We also confirm our annual target of converting 50-plus% of Consolidated Adjusted EBITDA into operating cash flow, which, coupled with our low maintenance CapEx needs of approximately 1% of annual revenue, generate attractive cash flow opportunities and, as a result, enables us to invest in our business, our strategy, and our people. Regarding cash flow, we were pleased to report significant improvement in our operating cash flow conversion to 40% of consolidated adjusted EBITDA in our third quarter. We expect operating cash flow to increase materially in the fourth quarter of this year through continued working capital improvement. And finally, we are reiterating our full year 2024 guidance ranges for revenue of $690 million-$740 million and consolidated adjusted EBITDA of $95 million-$100 million. We continue to see strong organic growth across most business lines and positive contributions from acquisitions, despite the delay earlier this year in the promulgation of the U.S. EPA's PFAS rules. These regulatory delays temporarily shifted project start dates beyond the second half of 2024 within our treatment technologies business line. It is important to note that since the U.S. EPA announced its drinking water PFAS rules in April 2024. Our quarterly treatment technology revenue has increased each quarter. That positive trend continued, with third quarter revenue growth over the second quarter. As we have discussed on prior calls, Montrose benefits from PFAS opportunities across all of our segments, not just within treatment technology. PFAS-related revenue in our laboratories is expected to increase approximately 30% in 2024 versus 2023, and PFAS-related consulting services are expected to increase approximately 75% in 2024 compared to 2023. This growth has been driven by market expansion and our successful cross-selling initiatives, and we remain confident in solid growth in total PFAS-related revenue in 2025. It is important to note that our segments are benefiting from multiple newly regulated and emerging contaminants, not just PFAS, though PFAS remains a significant near-term opportunity for us. Shifting now, I'd like to discuss a few recent key regulatory developments and some of the trends we are seeing in our business. As we discussed last quarter, we have seen very little impact to Montrose from the U.S. Supreme Court's decision in Loper Bright, which overruled the long-standing Chevron doctrine, allowing federal agencies to interpret ambiguous federal statutory provisions. However, this complexity and resulting short-term uncertainty from the Chevron decision drove increased demand for our advisory and consulting services, so our short and long-term business outlook remains unchanged. Regarding the political landscape and the outcome of the U.S. presidential election, we remain confident in our ability to perform per plan. As we've demonstrated historically, we grew rapidly during the Obama, Trump, and Biden administrations, as our business model is designed to be resilient and largely insulated from the political swings at the federal level. We expect this trend to hold true going forward, given our limited exposure to any one end market and the higher relative influence of state and local environmental regulations on our customer activity. In addition, the approximately 20% of our business in Canada, Australia, and Europe continues to perform, in aggregate and in each geography, very well. Overall, the fundamental drivers of demand for our environmental solutions remain strong, and the relative strategic advantages offered by our business model and our technology portfolio continue to prove out. As one example, our recent selection by the U.S. Army Corps of Engineers for our participation in a major environmental contract validated our approach and positions us well within the growing U.S. federal sector. In summary, I'm extremely proud of our team's exceptional performance this quarter, delivering record revenue and profitability while advancing our strategic priorities. In the near term, we look forward to delivering on our core organic growth opportunities and allowing our cash flow generation capabilities to shine as we focus on the redemption of the Series A2 preferred instrument and we de-emphasize acquisitions. As we look to 2025 and beyond, we remain very optimistic about our ability to drive shareholder value with our proven and consistent long-term strategic thesis, which remains unchanged. With that, I will hand it over to Allan. Thank you. Thanks, Vijay. We were pleased to deliver another quarter of strong financial performance as we continue to execute our growth strategy. Our solid results during the third quarter were driven by organic momentum from cross-selling activity and expanding customer relationships and the positive contributions of acquisitions. Our focus on higher margin services and operational efficiency continues to benefit our business, reflected in a notable improvement in our overall profitability to record levels. Moving to our revenue performance, our third quarter revenue increased to a record $178.7 million, or a 6.4% increase compared to the prior year quarter. Revenue for the first nine months of $507.4 million was a 10.7% increase versus the prior year period. The primary drivers of growth in the third quarter were strong organic growth in our assessment, permitting, and response and measurement and analysis segments, as well as positive contributions from acquisitions, partially offset by lower environmental emergency response revenue. The drivers of revenue growth in the first nine months were solid organic growth of 7% compared to the prior year-to-date period and the positive contributions from acquisitions, partially offset by lower environmental emergency response and treatment technology revenues. Our Consolidated Adjusted EBITDA performance in the third quarter reached a record $28.3 million, or 15.8% of revenue. This compares favorably to Consolidated Adjusted EBITDA of $23.3 million, or 13.9% of revenue in the prior year quarter. The significant increase in quarterly profitability, despite a substantial reduction in high-margin emergency response activity, was driven by organic growth, the impact of acquisitions, and lower corporate expenses, which is partially timing related. First nine months 2024 Consolidated Adjusted EBITDA was $68.5 million, or 13.5% of revenue, compared to Consolidated Adjusted EBITDA of $61.1 million, or 13.3% of revenue. Diluted Adjusted Net Income per share of $0.41 in the third quarter of 2024 increased from $0.31 in the prior year quarter. Year-to-date diluted Adjusted Net Income per share of $0.80 increased compared to $0.78 in the prior year period. The improvement in both periods was mainly driven by improved loss from operations and lower dividends following the partial redemption of our Series A2 preferred stock earlier this year, partially offset by higher interest expense and higher average share count. Please note our Adjusted Net Income per diluted share attributable to common stockholders is calculated using Adjusted Net Income attributable to stockholders divided by fully diluted shares. We believe this net income methodology is the most helpful net income metric to Montrose and to common equity investors. I will now discuss our third quarter performance by segment. In our assessment, permitting, and response segment, third quarter revenue was $52 million compared to $57 million in the prior year quarter. AP&R segment Adjusted EBITDA was $11.2 million, or 21.5% of revenue, compared to 26.1% in the prior year. Results during the third quarter reflect a $12.8 million reduction in high-margin environmental emergency response revenue, partially offset by strong organic growth in the rest of the segment and the positive impact of the Spirit acquisition. Given this segment includes our environmental emergency response business, associated revenue does not follow a regular quarterly or seasonal pattern. In our measurement and analysis segment, revenues for the quarter increased 16.1% to $58.6 million. We continue to experience strong organic revenue growth, particularly in our lab and field services businesses, as well as the positive contribution from our acquisition of Origins. M&A segment Adjusted EBITDA increased 29.2% to $13.4 million, or 22.8% of revenue, a 230 basis point improvement over the prior year quarter due to revenue growth and operating leverage. In our remediation and reuse segment, third quarter revenue increased 12.6% to $68.1 million, benefiting from acquisitions and solid organic growth in our remediation services, which more than offset the decline in our treatment technology revenue due to the temporary customer project delays that Vijay discussed earlier. This segment's Adjusted EBITDA and margin benefited from the impact of acquisitions and higher organic revenues in our remediation services, resulting in a 480 basis point margin improvement to 17.1% in the quarter. Moving to our cash flow and capital structure. Year-to-date cash flow used in operating activities was $9.7 million compared to cash generated of $41.5 million in the prior year. Lower cash flow from operations was driven primarily by the previously discussed invoicing delays associated with the integration of Matrix and delays in payment on a single large U.S. government-funded project. The invoicing delays at Matrix are substantially addressed, and collections are returning to a normal cadence. We have received payment confirmations from key clients, which includes the U.S. government. Excluding these two temporary and isolated issues, day sales outstanding as of September 30, 2024, were unchanged versus September 30, 2023, and DSOs at the end of 2024 are expected to be in line with DSOs at the end of 2023. Cash flow from operating activities is expected to improve significantly in the fourth quarter, mainly attributable to these working capital improvements. At the end of the quarter, we had $139.8 million of liquidity, including $13 million of cash on hand and $126.7 million of availability on our credit facility. Our leverage ratio as of September 30, 2024, was 2.6 times, which includes the impact of the acquisitions of Spirit and Origins, and is well within our preferred level of below three times. Our balance sheet simplification will continue to be a near-term priority of our capital allocation strategy. Historically, our capital deployment has been focused on accretive acquisitions and investments to drive organic growth. While acquisitions remain a key part of our long-term capital allocation, we are evolving our near-term capital allocation priorities to focus on balance sheet simplification, particularly as it relates to the redemption of our Series A2 preferred stock, while maintaining a focus on organic growth. As of September 30, 2024, we had $122 million of Series A2 outstanding, with repayment in cash at our election. Moving to our reiterated full-year outlook. Based on our performance through the first nine months and our visibility into the fourth quarter, we are reaffirming our full-year 2024 guidance ranges. For the full year, we expect revenues of $690-$740 million and consolidated Adjusted EBITDA of $95-$100 million. We continue to expect environmental emergency response revenue to be in the range of $50-$70 million this fiscal year. As we evaluate the final quarter of 2024 and compare it with the prior Q4 period, revenue is expected to increase 10%-15%, and consolidated Adjusted EBITDA margin is expected to increase 350-400 basis points. Our expectation of ongoing margin improvement reflects meaningfully enhanced profitability and demonstrates alignment of our strategic and financial goals. Overall, our reiterated outlook reflects the service offering and geographic diversification of our revenue, strength of our business year-to-date, and the continued benefits from our margin expansion initiatives, despite the temporary timing shifts in certain project work. We remain confident in our ability to execute through the remainder of the year and continue building momentum into 2025, given the increasing demand for our services. Thank you all for joining us today and for your continued interest in Montrose. We look forward to the opportunities we see ahead and updating you on our progress next quarter. Operator, we are ready to open the lines to questions. Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on their touch-tone phone. If you're using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star, then two. At this time, we will pause momentarily to assemble our roster. Our first question comes from Tim Mulrooney from William Blair. Please go ahead. Vijay, Allan, good morning. Hey, Tim. How are you? Doing well. Thank you. You actually addressed a lot of the questions I had in the chamber for the call today. You actually addressed a lot of them in your prepared remarks. So I'm actually going to move to a couple just more targeted questions. The first one is just on the Trump election win. I was wondering if you could which of your businesses did well under his prior administration, if you could highlight some of those, and what business lines would you expect to continue to perform well and thrive in this type of environment? Tim, why don't I start with that, and Allan, you can certainly jump in. Just as a quick reminder, we've been through our prior Trump administration before, as you alluded to, Tim, and we doubled in size and we went public during the Trump administration, so our business is, by definition, designed to go through, grow, and go through these political cycles. And as it relates to our revenue mix, where we saw a significant uptick in demand was in our consulting and our treatment side of our business last time, Tim, and some modulation on the testing side, and the reason for that is that the Trump EPA de-emphasized new regulations and de-emphasized certain forms of enforcement. As a result, as we kind of look across our business mix, we are feeling quite optimistic about the opportunity to continue our organic growth cadence that we've kind of talked about with you in the past, and our outlook is largely unchanged. The other dynamic that I think is important that is different from where we were in the prior Trump administration is that approximately 20% of our revenue is now ex-US. As we think about Canada, Europe, and Australia, we're seeing exceptional performance across all of those geographies, and we certainly don't expect that to change all that much either. We're feeling quite upbeat, Tim, and I don't know if that answers all of your questions. No, it did answer my question. Thank you, Vijay. Another one I wanted to ask about was in your 10-K, I noticed in your 10-K that your COO, Joshua LeMaire, is leaving the organization. I was just curious if you could share any more details about that decision and how that kind of impacts your organization. Yeah. No, Josh is still part of the organization. He's a friend and an exceptional colleague. For personal reasons, he's going to be stepping down from the COO role, but he's going to stay with us, help us transition with a new leader, both selecting and onboarding the new leader, Tim, and we're likely going to focus on someone with a deep bench of industry experience. But he's still part of Montrose. He was a core part of the founding team, and he's going to be working closely with me and Allan and the rest of the team going forward. So we're actually really thankful for everything Josh has done, and we're excited to kind of see what his next chapter looks like for him. Got it. Okay. Thank you for the color on that. That's helpful. Just one more from me. I know you're pausing acquisitions, but would just love to hear how some of these recent ones are going. Could you comment on Origins and Spirit in a little more detail? How are those going? Thank you, Vijay. Yeah. Both are actually going very well. Origins is a lab that really focuses in on Colorado and the mountain states, Tim, and the recent regulatory regime in those states has created a really nice set of tailwinds for that business, and it is performing exceptionally well. The team is excellent, and the integration has gone well. And what's been really encouraging for us is that some of our cross-selling of our clients into their business is progressing really nicely. So we're really pleased with that. And then the same goes for Spirit. They've been very additive as an air permitting powerhouse with an exceptional team. They've really been additive to our broader consulting and testing footprint and have already really hit stride with working across our service lines and our clients. And so I couldn't be more pleased with both of those. And even with some of the earlier transactions, Tim, like Epic and Two Dot, they are going incredibly well as well. So we're kind of, as we look across our portfolio of acquisitions from this year, notwithstanding some of the things we talked about earlier, which are normal as you integrate acquisitions, we're really happy. And all of those transactions in aggregate have been really accretive to our growth profile, to our margin profile, and we think we'll stay that way long term. Helpful color. Thank you, Vijay. Thank you. The next question comes from Durgesh Chopra from Evercore ISI. Please go ahead. Hey, Tim. Good morning. Thanks for giving me time. Hey, Durgesh. How are you? Hey, Vijay. Good morning. Allan, good morning. Hey, just on this de-emphasizing acquisitions and no equity, can you just kind of help us with time? Is this for a what time period is that over is what I'm trying to go with this? Is this first half of 2025, no equity, all of 2025, gets into 2026? How should we think about that? Yeah. Durgesh, we're going to be de-emphasizing acquisitions and really focusing on the redemption of the Oaktree pref and on organic growth. We're excited to kind of demonstrate the kind of the engine that drives our organic growth profile and our cash flow profile. In aggregate, just to kind of step back, our thesis is unchanged. So there is still a very robust pipeline of accretive transactions that we think will be very additive long term. And so we're going to let the business, over the next couple of quarters, demonstrate the power of the organic engine and allow us to repay the pref. And then we're going to target kind of that three-ish times leverage, right, for select transactions. We may pop up above three to three and a half. And we're kind of well in the twos right now. And so we're going to keep it to kind of those parameters, Durgesh. It's a little tough to predict exactly what deal flow looks like, but our intent over the next couple of quarters is to de-emphasize the acquisitions. And as it relates to the equity issuance and our specific focus on repaying the prep, we do not intend to issue any equity to repay that. Got it. Allan, I don't know if there's anything else you would add as it relates to the balance sheet. No, that's exactly right. We've got certainly the leverage capacity and the financing capacity to take out the prep. The next $60 million is due in April anyway, so you'll see us take that out before that. And then the final $62 million, likely shortly after that again, depending on how the year is progressing, but that would be our expectation. That's helpful, guys. But just to be clear, though, you're not saying no acquisitions. All you're saying is you'll probably kind of manage within that leverage metric there. There could be still more acquisitions, but you're not tapping the equity market. Is that fair? That's the broad thesis, Durgesh. And just to be clear, for the immediate future, we will likely not transact, but it doesn't mean we never will. And going back to my earlier point, a core part of our strategy is to consolidate select parts of this market, given our business model, and use that consolidation to drive accelerated organic growth. And that thesis is unchanged. It's just where our focus is going to be through Q4, Q1, and Q2. Okay. Perfect. Thank you. Appreciate the time. Thanks, Durgesh. Thank you. A reminder to the participants. If you would like to register for a question, please press star and one on your touch-tone phone. The next question comes from James Ricchiuti from Needham & Company. Please go ahead. Hi. Good morning. Hey, Jim. Question. Vijay, just a question on the decision regarding M&A. I'm just wondering, is there any risk that this decision potentially could represent lost opportunities for you guys? No. Jim, we're staying very close to our core target opportunities. And at this time, there is absolutely no risk to us losing anything that we really want. Okay. And look, I know that this decision was obviously something that preceded the election, but I'm also wondering, does this perhaps reinforce the decision on M&A deleveraging just until there's more clarity on how the regulatory environment might evolve if there's any change at all? And it doesn't sound like you think there is, but do you feel more comfortable with this decision now? I mean, we're certainly in a we want to see how the new Trump administration and President Trump and his EPA progress, Jim, and then we want to see kind of what the state decisions are. We don't expect, honestly, with what we currently do, much to change, and we know folks that were in the prior Trump administration that are involved with a lot of the planning processes now, so we don't expect much to change, but yes, I think the focus on driving our organic and harvesting what we already have in hand while we wait to see what the next couple of months look like. We made the decision independent of that, but we certainly think it's going to be very additive given the current circumstances. Yes. Got it. And just final question from me. I'm wondering how we should be thinking about your selection by the Army Corps of Engineers. Regarding that announcement, are there any expected milestone awards that you're tracking that are in the line of sight for the next year or two? I'm just wondering how we should think about the announcement. Thank you. Yeah. It was great because it kind of validated, Jim, as we've talked about with you in the public sector, our strategic thesis, and it enabled us to kind of leverage both our advisory testing capabilities and our engineering and remediation capabilities. And so yes, there will be milestones as that contract process progresses, and we'll certainly keep all of you abreast of that. And obviously, that's not the only one. There's others that we're quite optimistic about. So we'll stay close to you as that progresses. I think the only point of highlighting that is that the broader opportunity set is incredibly strong, and our relative advantage to harvest that broader opportunity set, which is expanded, also seems to be manifesting really nicely. So we'll stay very close to you as those awards start to come to fruition and translate into revenue. Got it. Thank you. Thank you. The next question comes from from Aadit Shrestha Stifel. Please go ahead. Hi, Aadit. Hi. Good morning. Thanks for taking my questions. Just going to sort of the outlook for 4Q24, I think you talked about revenue growth being 10%-15%. Could you just elaborate about how much of that is from acquisitions and emergency response? I think your guidance kind of infers is likely up 20% plus, so for a strong quarter. And then acquisitions, it looks like it's at around 9% in 3Q24. Does this temper down slightly in 4Q? Yeah. Let me speak about kind of 4Q and the year a little bit more broadly of it because I want to make sure we're kind of keeping in line with all of the publicly disclosed information. Most of our business lines are seeing double-digit organic growth, which we're really excited about. And the two variables that are swinging Q4 in the numbers you just referenced are, one, the temporary delays in some of the treatment technology projects, and two, the relative magnitude of the response business. And so despite those two, right, the response is we kind of think about year on year, as Allan alluded to in his comments, are down. The core organic, plus the impact of acquisitions, is driving some of our optimism into Q4 and 2024. And so that's the reason we're maintaining our guidance. On the response side specifically, the team has done an exceptional job this year. We're still expecting that to be in the $50 million-$70 million range. It was a little lighter in Q3. We expect, given the hurricane and recent events, that it may be on the higher end of that $50 million-$70 million in Q4, but it's very tough to predict, as you know. And so that's the one reason for that range that you saw in the public comments that Allan provided. Does that make sense of it? Yep. Thanks a lot, and maybe if you could just elaborate on Matrix margins. How did that perform in 3Q24? I know you discussed you remain on track of attaining mid-teens margin. Do we actually see that in 4Q or? Yeah. Allan, do you want to take that? Yeah. They ran at mid-teens margins, so really solid Q3 performance. Year over year, they are expected to have tripled their margins from the time of acquisition. That team is performing exceptionally, and all of the initiatives to drive that margin, which is pricing, operational excellence, if you will, and then the cost savings through the integration activities are all going per plan, and that is resulting in us being exactly where we would have hoped at this time. And just as a follow-up, are you seeing a strong organic growth within Matrix too in terms of? We are seeing really solid organic. Yes. We had expected that with the pricing that was taken, that we would not see much growth, that there would be some volume attrition. We have not seen that and credit again to the Matrix team. So they are seeing really nice organic growth for them. Now, not all of that counts in our organic growth, right, because the first five months was still considered acquisition growth. But certainly, in the back half of the year, they're seeing really nice organic growth. All right. Thanks a lot. Thanks, Aadit. Thank you. This concludes our question and answer session. I would now like to turn the conference back over to Vijay Manthripragada, CEO, for any closing remarks. Thank you. And thank you all for taking the time this morning. We really appreciate your continued support. Allan and I and the Montrose team are really excited about the year, the quarter, and our outlook into 2025. And so we certainly look forward to sharing more with you in the very near future. Thank you and take care. Thank you. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.